Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist

被引:17
作者
Eastwood, Paul [1 ]
Esteve, Cristina [1 ]
Gonzalez, Jacob [1 ]
Fonquerna, Silvia [1 ]
Aiguade, Josep [1 ]
Carranco, Ines [1 ]
Domenech, Teresa [1 ]
Aparici, Monica [1 ]
Miralpeix, Montserrat [1 ]
Alberti, Joan [1 ]
Cordoba, Monica [1 ]
Fernandez, Raquel [1 ]
Pont, Merce [1 ]
Godessart, Nuria [1 ]
Prats, Neus [1 ]
Isabel Loza, Maria [2 ]
Isabel Cadavid, Maria [2 ]
Nueda, Arsenio [1 ]
Vidal, Bernat [1 ]
机构
[1] Almirall, R&D Ctr, Barcelona 08980, Spain
[2] Univ Santiago Compostela, Fac Pharm, Discovery Grp BioFarma, Santiago De Compostela 15782, Spain
关键词
A(2B) adenosine receptor antagonist; ovalbumin mouse model; clinical candidate; PULMONARY INFLAMMATION;
D O I
10.1021/ml100249e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The structure activity relationships for a series of pyrazine-based A(2B) adenosine receptor antagonists are described. From this work, LAS101057 (17), a potent, selective, and orally efficacious A(2B) receptor antagonist, was identified as a clinical development candidate. LAS101057 inhibits agonist-induced IL-6 production in human fibroblasts and is active in an ovalbumin (OVA)-sensitized mouse model after oral administration, reducing airway hyperresponsiveness to methacholine, Th2 cytokine production, and OVA-specific IgE levels.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 23 条
[1]   Release of ATP during host cell killing by enteropathogenic E-coli and its role as a secretory mediator [J].
Crane, JK ;
Olson, RA ;
Jones, HM ;
Duffey, ME .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (01) :G74-G86
[2]   Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists [J].
Eastwood, Paul ;
Gonzalez, Jacob ;
Paredes, Sergio ;
Nueda, Arsenio ;
Domenech, Teresa ;
Alberti, Joan ;
Vidal, Bernat .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) :1697-1700
[3]   Discovery of potent and selective bicyclic A2B adenosine receptor antagonists via bioisosteric amide replacement [J].
Eastwood, Paul ;
Gonzalez, Jacob ;
Paredes, Sergio ;
Fonquerna, Silvia ;
Cardus, Arantxa ;
Antonio Alonso, Juan ;
Nueda, Arsenio ;
Domenech, Teresa ;
Reinoso, Raquel F. ;
Vidal, Bernat .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) :1634-1637
[4]   Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells [J].
Fredholm, BB ;
Irenius, E ;
Kull, B ;
Schulte, G .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (04) :443-448
[5]   A2B adenosine receptors in immunity and inflammation [J].
Hasko, Gyoergy ;
Csoka, Balazs ;
Nemeth, Zoltan H. ;
Vizi, E. Sylvester ;
Pacher, Pal .
TRENDS IN IMMUNOLOGY, 2009, 30 (06) :263-270
[6]   Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases [J].
Hasko, Gyorgy ;
Linden, Joel ;
Cronstein, Bruce ;
Pacher, Pal .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :759-770
[7]   The identification of the adenosine A2B receptor as a novel therapeutic target in asthma [J].
Holgate, ST .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (08) :1009-1015
[8]   Enhanced mast cell activation in mice defi cient in the A2b adenosine receptor [J].
Hua, Xiaoyang ;
Kovarova, Martina ;
Chason, Kelly D. ;
Nguyen, MyTrang ;
Koller, Beverly H. ;
Tilley, Stephen L. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (01) :117-128
[9]   A comprehensive listing of bioactivation pathways of organic functional groups [J].
Kalgutkar, AS ;
Gardner, I ;
Obach, RS ;
Shaffer, CL ;
Callegari, E ;
Henne, KR ;
Mutlib, AE ;
Dalvie, DK ;
Lee, JS ;
Nakai, Y ;
O'Donnell, JP ;
Boer, J ;
Harriman, SP .
CURRENT DRUG METABOLISM, 2005, 6 (03) :161-225
[10]   A2B adenosine receptor gene deletion attenuates murine colitis [J].
Kolachala, Vasantha L. ;
Vijay-Kumar, Matam ;
Dalmasso, Guillaiume ;
Yang, Dan ;
Linden, Joel ;
Wang, Lixin ;
Gewirtz, Andrew ;
Ravid, Katya ;
Merlin, Didier ;
Sitaraman, Shanthi V. .
GASTROENTEROLOGY, 2008, 135 (03) :861-870